Results 111 to 120 of about 268 (127)

Serological and molecular studies of HLA in Sardinian patients with Graves'disease.

open access: yes, 1992
LA NASA, GIORGIO   +6 more
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

[Malt lymphoma of the thyroid and Graves'disease].

Annales d'endocrinologie, 2002
Maltoma of the thyroid associated to Graves'disease is not such a frequently described association. We report a case of Maltoma of the thyroid gland in a patient with Grave's disease. The diagnosis was established by histological examination after total thyroidectomy.
F, Djrolo   +5 more
openaire   +1 more source

DQA2 U ALLELE: A GENETIC MARKER FOR RELAPSE OF Graves'DISEASE

Clinical Endocrinology, 1990
SUMMARYThe association of HLA‐DR3 with Graves'disease in Caucasoids is well established but its significance is unclear and its clinical value as a predictive parameter for relapse after a course of antithyroid drug therapy is controversial. We have further investigated the predictive value at the genomic level in 51 patients with Graves'disease who ...
S, Ratanachaiyavong   +5 more
openaire   +2 more sources

CORRELATION OF ORBITAL COMPUTED TOMOGRAPHY AND ANTIBODIES IN PATIENTS WITH HYPERTHYROID Graves'DISEASE

Clinical Endocrinology, 1990
SUMMARYThe purpose of this study was to elucidate the incidence of orbital changes in computed tomography, and the relationships of orbital changes with eye‐muscle antibody (EMAb), thyrotrophin‐binding inhibitor immunoglobulin (TBII), antithyroglobulin antibody (TgAb) and anti‐thyroid microsomal antibody (MsAb), in 55 consecutive patients with ...
T C, Chang   +3 more
openaire   +2 more sources

ANALYSIS OF HLA‐DQB AND HLA‐DPB ALLELES IN Graves'DISEASE BY OLIGONUCLEOTIDE PROBING OF ENZYMATICALLY AMPLIFIED DNA

Clinical Endocrinology, 1990
SUMMARYWe have tested the possible association of HLA‐DQB and HLA‐DPB alleles with Graves'thyrotoxicosis, with or without severe ophthalmopathy, by polymerase chain amplification of genomic DNA and allele‐specific oligonucleotide probing. There was no significantly abnormal distribution of DQB alleles compared to 50 control subjects except for a ...
A P, Weetman   +3 more
openaire   +2 more sources

[Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report].

Acta medica Austriaca, 2002
We present the case of a 60-year old woman with painful swelling of the thyroid gland and temporary thyrotoxicosis. 30 years ago she had experienced a period of hyperthyroidism because of Graves' disease. This time thyrotropin-receptor-antibodies were negative, Tc-99 m scan revealed decreased uptake in both lobes (this pattern normalised later on) and ...
R, Pichler   +5 more
openaire   +1 more source

Graves'DISEASE IN PREGNANCY: TSH RECEPTOR BINDING INHIBITING IMMUNOGLOBULINS AND MATERNAL AND NEONATAL THYROID FUNCTION

Clinical Endocrinology, 1990
SUMMARYWe studied interrelationships between maternal and neonatal thyroid function, TSH receptor binding inhibiting immunoglobulins (TBII), and dose of thionamide antithyroid drugs in 44 women with active Graves'disease presenting during 46 pregnancies, and their 48 infants. The women were treated with propylthiouracil (PTU) or carbimazole (CBZ).
Mortimer, RH   +4 more
openaire   +5 more sources

Coexistence of Graves’ disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels

Journal of Endocrinological Investigation, 2005
Struma ovarii is the most common monodermal ovarian teratoma and consists mainly of thyroid tissue. Only 5% of patients with this tumor have features of hyperthyroidism. The pathophysiology of hyperthyroidism in struma ovarii is not clear.We describe a case of benign struma ovarii, presenting with the clinical features of an ovarian cancer: large ...
GUIDA, MAURIZIO   +5 more
openaire   +5 more sources

Antithyroid drugs in the treatment of hyperthyroidism of Graves'disease: Long-term follow-up of 434 patients

2012
A study of antithyroid (ATD) therapy with a mean follow-up period of 10 years (range 2-25) in 434 patients with Graves'diseases has been made by linking hospital records with those of a central follow-up register. The majority (89%) were treated with carbimazole and 87% received combined therapy with triiodothyronine (T3) (73%) or thyroxine (T4) (14%).
Hedley, AJ   +4 more
openaire   +1 more source

Antithyroid antibodies (TgAb,MAb) and outcome of graves'disease (Gd)

Journal of Steroid Biochemistry, 1984
S. Benvenga   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy